ESC 365 - Optimizing clinical outcomes in acute decompensated heart failure. The role of Landiolol.

Open Access

Optimizing clinical outcomes in acute decompensated heart failure. The role of Landiolol.

Session: When the heart begins to race acutely - overcoming existing therapy limits with Landiolol

Topic: Cardiovascular Pharmacotherapy

Speaker: Doctor M. Sramko (Prague, CZ)

Sponsored by AOP Health

Event: Heart Failure 2022

Congress Presentation

Add to my library

About the speaker

Doctor Marek Sramko

Institute for Clinical and Experimental Medicine (IKEM), Prague (Czechia)

1 presentation

0 follower

2 more presentations in this session

Short acting beta-blockers in critical ill patients.

Speaker: Associate Professor W. Speidl (Vienna, AT)

Questions & Answers.

Speaker: Professor G. Dan (Bucharest, RO)

Access the full session

When the heart begins to race acutely - overcoming existing therapy limits with Landiolol

Speakers: Doctor M. Sramko, Associate Professor W. Speidl, Professor G. Dan

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources